Back to Search
GRACE MCCOMSEY, MD
MD
Infectious Disease Physician
NPI: 1720004336IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
35-064769(OH)35064769(OH)
Pediatric Infectious Diseases Physician
Pediatrics — Pediatric Infectious Diseases
Code: 2080P0208X
35-064769(OH)
Education
OTHER
Class of 1989
Research & Publications (20)
Changes in body composition with ritonavir-boosted and unboosted atazanavir treatment in combination with Lamivudine and Stavudine: a 96-week randomized, controlled study.
PMID 19302017·Clin Infect Dis·2009
2-rct
Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection.
PMID 18771055·Antivir Ther·2008
8-other
Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices.
PMID 17538545·Eur J Clin Nutr·2008
8-other
Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.
PMID 18444869·Clin Infect Dis·2008
2-rct
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
PMID 18025884·AIDS·2007
4-observational
Increased carotid intima media thickness and cardiac biomarkers in HIV infected children.
PMID 17457085·AIDS·2007
8-other
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.
PMID 15627029·AIDS·2005
8-other
Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.
PMID 15905734·J Acquir Immune Defic Syndr·2005
8-other
Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies.
PMID 16120376·Mitochondrion·2004
8-other
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
PMID 14699460·Clin Infect Dis·2004
3-trial
Mitochondrial dysfunction: patient monitoring and toxicity management.
PMID 15319667·J Acquir Immune Defic Syndr·2004
8-other
Asymptomatic hyperlactataemia: predictive value, natural history and correlates.
PMID 15134182·Antivir Ther·2004
8-other
Lipid oxidative markers are significantly increased in lipoatrophy but not in sustained asymptomatic hyperlactatemia.
PMID 14501792·J Acquir Immune Defic Syndr·2003
8-other
Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy.
PMID 12902805·J Acquir Immune Defic Syndr·2003
3-trial
Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
PMID 12612284·Pediatrics·2003
4-observational
Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy.
PMID 14649623·AIDS Read·2003
8-other
Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy.
PMID 11872993·AIDS·2002
8-other
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia.
PMID 12061328·AIDS Read·2002
5-case
Treatment options for HIV-associated central fat accumulation.
PMID 19055407·AIDS Patient Care STDS·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVENUE
CLEVELAND, OH 44106 - Phone
- (216) 844-7700
Quick Facts
- NPI
- 1720004336
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile